Emergent BioSolutions
EBS
#6608
Rank
ยฃ0.53 B
Marketcap
ยฃ9.94
Share price
-3.88%
Change (1 day)
21.76%
Change (1 year)

Market capitalization of Emergent BioSolutions (EBS)

Market cap: ยฃ0.53 Billion

As of January 2026 Emergent BioSolutions has a market cap of ยฃ0.53 Billion. This makes Emergent BioSolutions the world's 6608th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Emergent BioSolutions from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ0.53 B7.69%
2025ยฃ0.49 B37.9%
2024ยฃ0.35 B265.33%
2023ยฃ97.74 M-79.93%
2022ยฃ0.48 B-71.89%
2021ยฃ1.73 B-50.27%
2020ยฃ3.48 B63.79%
2019ยฃ2.12 B-11.04%
2018ยฃ2.39 B39.37%
2017ยฃ1.71 B59.17%
2016ยฃ1.07 B1.31%
2015ยฃ1.06 B61.31%
2014ยฃ0.65 B29.21%
2013ยฃ0.51 B43.4%
2012ยฃ0.35 B-8.62%
2011ยฃ0.38 B-26.79%
2010ยฃ0.53 B105.49%
2009ยฃ0.25 B-51.42%
2008ยฃ0.53 B603.46%
2007ยฃ75.77 M-51.81%
2006ยฃ0.15 B

End of Day market cap according to different sources

On Jan 8th, 2026 the market cap of Emergent BioSolutions was reported to be:

ยฃ0.52 Billion
by Nasdaq info icon info icon
ยฃ0.53 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Merck
MRK
ยฃ206.25 B 38,794.55%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
ยฃ0.36 B-31.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ75.51 B 14,139.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
ยฃ1.35 B 154.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ106.97 B 20,073.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ27.74 B 5,132.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
ยฃ10.8 M-97.96%๐Ÿ‡บ๐Ÿ‡ธ USA